Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLS

SELLAS Life Sciences Group Inc

May 29 • 04:00PM ET

9.31

+0.13 1.42 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA TNGX CGON RCUS NUVL BMRN KYMR RYTM INCY KRYS

| Held by: XBI IWM VTI IWO VXF VFMO VTWO IWC PTH DWAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.23	Insider Own	0.44%	Shs Outstand	186.03M	Perf Week	23.15%
Market Cap	1.73B	Forward P/E	-	EPS next Y	-0.15	Insider Trans	0.00%	Shs Float	185.21M	Perf Month	99.36%
Enterprise Value	1.63B	PEG	-	EPS next Q	-0.05	Inst Own	32.66%	Short Float	30.81%	Perf Quarter	88.84%
Income	-29.46M	P/S	-	EPS this Y	16.00%	Inst Trans	10.47%	Short Ratio	7.58	Perf Half Y	546.53%
Sales	0.00M	P/B	15.72	EPS next Y	28.57%	ROA	-39.50%	Short Interest	57.07M	Perf YTD	146.95%
Book/sh	0.59	P/C	16.16	EPS next 5Y	50.68%	ROE	-43.58%	52W High	9.23 0.81%	Perf Year	444.44%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-27.35%	52W Low	1.39 569.78%	Perf 3Y	454.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.00% 10.07%	Perf 5Y	-22.16%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	41.60%	Oper. Margin	-	ATR (14)	0.74	Perf 10Y	-99.98%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	17.22	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	72.90	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.22	EPS Q/Q	26.44%	SMA20	37.12%	Beta	2.49	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	66.80%	Rel Volume	3.43	Prev Close	9.18
Employees	13	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	168.82%	Avg Volume	7.53M	Price	9.31
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.67% -	Trades		Volume	25,822,002	Change	1.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)